<DOC>
	<DOCNO>NCT01708525</DOCNO>
	<brief_summary>Enrolled subject undergo tissue label evaluate rate collagen synthesis tissue treat Ulthera® System compare control tissue .</brief_summary>
	<brief_title>Feasibility Study : Heavy Water Tissue Labeling Protocol</brief_title>
	<detailed_description>This study prospective , single-center , blind , non-randomized clinical trial . Two subject choose surgical facelift procedure agree drink heavy water tissue labeling , enrol . Subjects consume heavy water collect saliva specimen course study period , follow specific heavy water label protocol . Two week start heavy water protocol , subject return study site receive one Ultherapy® treatment pre-auricular region one side face . The contra-lateral pre-auricular region serve control . Following Ultherapy® treatment , subject continue follow heavy water protocol 4 week . Subjects return study site undergo resection treat control tissue analysis plan rhytidectomy procedure . Subjects send saliva sample weekly basis allow confirmation drink heavy water .</detailed_description>
	<mesh_term>Cutis Laxa</mesh_term>
	<mesh_term>Deuterium Oxide</mesh_term>
	<criteria>Male female , age 30 65 year schedule rhytidectomy . Subject good health . Understands accepts obligation undergo procedure area treat . Willingness ability comply protocol requirement , include return followup visit abstain exclusionary procedure duration study . Subjects childbearing potential must negative urine pregnancy test result must lactate Visit 1 willing able use acceptable method birth control . Absence physical psychological condition unacceptable investigator . Willingness ability provide write consent studyrequired photography adherence photography procedure ( i.e. , removal jewelry makeup ) . Willingness ability provide write informed consent HIPAA authorization prior performance studyrelated procedure . Presence active systemic local skin disease may affect wound healing . Severe solar elastosis . Significant scar area treat . Open wound lesion area treat . Severe cystic acne area treat . Presence metal stent implant facial area treat . Inability understand protocol give inform consent . Microdermabrasion , prescription level glycolic acid treatment submental area within two week prior study participation study . Excessive dermatochalasis , deep dermal scarring , thick sebaceous skin area treat . BMI equal great 30 .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Ulthera® System</keyword>
	<keyword>Ultherapy® Treatment</keyword>
	<keyword>Ulthera , Inc .</keyword>
	<keyword>Ultrasound treatment skin tightening</keyword>
</DOC>